Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.

Infection and Immunity
Thomas R Kozel, J L Follette

Abstract

Antisera prepared in rabbits against either whole encapsulated cells of Cryptococcus neoformans or purified cryptococcal polysaccharide were opsonic for the encapsulated yeast. The opsonic activity was removed by absorption with whole cryptococci and was inhibited by free polysaccharide. As little as 0.13 microgram of cryptococcal polysaccharide produced a 50% inhibition of opsonization. Various degrees of neutralization by polysaccharides from the four cryptococcal serotypes suggested that the opsonins were type specific. Fractionation of antiserum on Bio-Gel A-5m (Bio-Rad Laboratories) and diethylaminoethyl cellulose showed that the opsonins were antibodies of the immunoglobulin G class. These opsonizing antibodies did not require heat-labile serum components for optimal phagocytosis of the yeast. Inhibition studies using 2-deoxy-D-glucose demonstrated that ingestion of encapsulated cryptococci opsonized with anticapsular antibody was a 2-deoxy-D-glucose-inhibitable process. This result differed from similar studies with non-encapsulated cryptococci which showed that ingestion of non-encapsulated cryptococci opsonized with normal serum was not inhibited by 2-deoxy-D-glucose.

Citations

Mar 19, 1982·Mycopathologia·R A Fromtling, H J Shadomy
Feb 1, 1986·Mycopathologia·R A Fromtling, H J Shadomy
Jan 1, 1985·Microbiology and Immunology·K KagayaS Saito
Jan 1, 2014·Yeast·Deepa SrikantaTamara L Doering
Dec 25, 2004·Infection and Immunity·Ryan M KellyStuart M Levitz
Apr 13, 2010·Eukaryotic Cell·Kerstin Voelz, Robin C May
Jan 16, 2018·Journal of Fungi·Liliane Mukaremera, Kirsten Nielsen
Aug 1, 1995·Trends in Microbiology·T R Kozel
Nov 1, 1995·Infection and Immunity·A Casadevall
Nov 1, 1991·Infection and Immunity·H L Collins, G J Bancroft
Nov 1, 1992·Infection and Immunity·J MukherjeeA Casadevall
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·S L ZebedeeA Casadevall
Oct 1, 1987·Oral Surgery, Oral Medicine, and Oral Pathology·D P Lynch, L Z Naftolin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.